Genetic Technologies
GENE
#10486
Rank
โ‚ฌ3.18 M
Marketcap
0,66ย โ‚ฌ
Share price
0.00%
Change (1 day)
-71.55%
Change (1 year)

Genetic Technologies (GENE) - Cash on Hand

Cash on Hand as of June 2024 : โ‚ฌ0.58 Million

According to Genetic Technologies's latest financial reports the company has โ‚ฌ0.58 Million in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Genetic Technologies - Cash on Hand chart (from 2004 to 2024)

Cash on Hand by year

Year Cash on Hand Change
2024-06-30โ‚ฌ0.63 M-86.64%
2023-06-30โ‚ฌ4.76 M-38.19%
2022-06-30โ‚ฌ7.7 M-41.84%
2021-06-30โ‚ฌ13.24 M52.37%
2020-06-30โ‚ฌ8.69 M560.03%
2019-06-30โ‚ฌ1.31 M-62.08%
2018-06-30โ‚ฌ3.47 M-53.09%
2017-06-30โ‚ฌ7.4 M-1.59%
2016-06-30โ‚ฌ7.52 M-40.49%
2015-06-30โ‚ฌ12.64 M548.6%
2014-06-30โ‚ฌ1.94 M43.74%
2013-06-30โ‚ฌ1.35 M-81.21%
2012-06-30โ‚ฌ7.21 M91.55%
2011-06-30โ‚ฌ3.76 M69.38%
2010-06-30โ‚ฌ2.22 M-50.16%
2009-06-30โ‚ฌ4.46 M-45.43%
2008-06-30โ‚ฌ8.17 M-2.64%
2007-06-30โ‚ฌ8.39 M34.45%
2006-06-30โ‚ฌ6.24 M-44.67%
2005-06-30โ‚ฌ11.28 M75.34%
2004-06-30โ‚ฌ6.43 M81.86%
2003-06-30โ‚ฌ3.54 M-12.6%
2002-06-30โ‚ฌ4.05 M940.43%
2001-06-30โ‚ฌ0.38 M-49.62%
2000-06-30โ‚ฌ0.77 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Eterna Therapeutics
ERNA
โ‚ฌ2.61 M 346.06%๐Ÿ‡บ๐Ÿ‡ธ USA
Myriad Genetics
MYGN
โ‚ฌ0.12 B 21,185.54%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
โ‚ฌ0.51 B 87,457.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
โ‚ฌ0.37 B 63,141.75%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
โ‚ฌ73.94 M 12,502.68%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel
Danaher
DHR
โ‚ฌ1.31 B 223,588.43%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
โ‚ฌ3.04 B 519,009.40%๐Ÿ‡บ๐Ÿ‡ธ USA
Neogen
NEOG
โ‚ฌ0.11 B 20,231.49%๐Ÿ‡บ๐Ÿ‡ธ USA